-
Therapeutic rating scores
Database contains the therapeutic rating scores for new active substances from the Patented Medicine Prices Review Board and from Prescrire International. -
Additional file 4: of Performance of InSilicoVA for assigning causes of death...
Misclassification matrix for neonatal deaths when InSilicoVA is trained using Tariff 2.0 symptoms without health care experience questions. (XLSX 5 kb) -
Additional file 14: of Volume-outcome relationship on survival and cost benef...
Figure S7. Association between annual severe burn patient volume and the adjusted risk of (A) in-hospital survival, (B) total healthcare costs, and (C) hospital-free days at 90â... -
Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimen...
Background: Drug-resistant tuberculosis (DR-TB) continues to be a major public health challenge with suboptimal treatment outcomes including well-documented treatment-related... -
dedup_wf_001--3ef0376ed3aadbc4f2e8b0f736b82989
Supplemental Tables for a study Contractile activity-specific transcriptome response to acute endurance exercise and training in human skeletal muscle Am J Physiol... -
Outlier analysis data and scripts
Compressed archive contains R script for identifying clusters in outlier SNP regions. Outlier SNP data is also included -
Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a r...
Cannabinoid receptor agonists are moderately effective at reducing neuropathic pain but are limited by psychoactivity. We developed a styrene maleic acid (SMA) based on the... -
ACF database on the anthropometric and programmatic outcomes from the MANGO t...
This dataset contains the variables used to analyse the main outcomes of the MANGO trial (including anthropometric data and programmatic outcomes) carried out in Burkina Faso... -
dedup_wf_001--0d9e9999ed26dc21021b4f45f4f392c2
Multiparasitism assay investigating internal competition between two parasitoid when attacking aphid with different resistance traits. -
Family physicians’ perceptions of pharmacists prescribing in Alberta
Canadian pharmacists now have prescribing authority and little is documented about the physicians’ perception, experience and relational dynamics evolving around the... -
GPS Dataset for dryad and BEI Final
This is the analyzable dataset for our BMJ paper evaluating data sharing and clinical trial transparency practices of large pharma companies with drugs approved by the FDA in... -
Rice Grain Quality and Consumer Preferences: A Case Study of Two Rural Towns ...
Hedonic pricing analysis is conducted to determine the implicit values of various attributes in the market value of a good. In this study, hedonic pricing analysis was applied... -
Additional file 3: of Changes over time in prescription practices of pain med...
Reimbursement of claims for strong opioid substances in morphine equivalent dose (MED) and treatment days per 100â000 persons. (ZIP 187Â kb) -
dedup_wf_001--607a76b17ff25f5a53dce3e88eaa3687
Data base of prescriptions collected by the largest social insurance fund, EOPYY during the first and last trimester of 2012. Extracted information included active substance,... -
Psychosocial interventions for stroke survivors, carers and survivor-carer dy...
Objective: To evaluate the effectiveness of psychosocial interventions on depressive symptoms, anxiety symptoms, quality of life, self-efficacy, coping, carer strain and carer... -
A comparison of disease burden and the government budget for mental health in...
Background: The lifetime prevalence of mental disorders in South Korea was 25.4% in 2016. The Act on Mental Health enabled the expansion of psychiatric facilities; however,... -
http://www.ncbi.nlm.nih.gov/bioproject/PRJNA309342
BioProject id for all raw reads (http://www.ncbi.nlm.nih.gov/bioproject/PRJNA309342) -
Additional file 6: of Volume-outcome relationship on survival and cost benefi...
Figure S3. Association between annual severe burn patient volume and adjusted risk of (A) in-hospital survival, (B) total healthcare costs, and (C) hospital-free days at 90â...
